A latest study has shown that the molecular weight of NBCn1 is consistently higher in breast cancer tissues compared to that in normal tissues [34], suggesting a change in alternative splicing of SLC4A7 products, although it could also be due to a change in protein modification. This evidence concerns the gene SLC4A7 and breast cancer.